The population pharmacokinetics of theophylline during the early postnatal period

Journal of Pharmacokinetics and Biopharmaceutics - Tập 19 - Trang S59-S77 - 1991
Emory S. Martin1
1College of Pharmacy, University of Texas, Austin

Tóm tắt

The following conclusions may be drawn from this study's results:

Tài liệu tham khảo

W.J.R. Daily, M. Klaus, and H.B.P. Meyer. Apnea in premature infants: Monitoring, incidence, heart rate changes, and an effect of environmental temperature,Pediatrics 43:510–518 (1969). H. Rigatto and J.P. Brady. Periodic breathing and apnea in preterm infants. I. Evidence for hypoventilation possibly due to central respiratory depression,Pediatrics 50:202–217 (1972). D.H. Kelly and D.C. Shannon. Periodic breathing in infants with near-miss sudden infant death syndrome,Pediatrics 63:355–360 (1979). J.T. McBride. Infantile apnea,Pediatrics Rev. 5:275–285 (1984). E.R. Alden, T. Mandelkorn, D.E. Woodrum, et al. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery,Pediatrics 50:40–49 (1972). E. Bacola, F.C. Behrle, L. de Schweinitz, H.C. Miller, and M. Mira. Perinatal and environmental factors in late neurogenic sequelae,Am. J. Dis. Child. 112:359–367 (1966). H. Rigatto. Apnea,Pediatr. Clin. North Am. 29:1105–1116 (1982). J. Kattwinkel. Neonatal apnea: Pathogenesis and therapy,J. Pediatr. 90:342–347 (1977). R.C. Banagale, D.W. Roloff, and W.F. Howatt. Apnea in newborn infants: Approach to management,Resuscitation 11:9–20 (1984). J.V. Aranda, D. Grondin, and B.L. Sasynick. Pharmacologic considerations in the therapy of neonatal apnea,Pediatr. Clin. North Am. 28:113–133 (1981). J.V. Aranda, D.S. Sitar, W.D. Parsons, et al. Pharmacokinetic aspects of theophylline in premature newborns,N. Engl. J. Med. 295:413–416 (1976). G. Giacoia, W.J. Jusko, J. Menke, and J.R. Koup. Theophylline pharmacokinetics in premature infants with apnea,J. Pediatr. 89:829–832 (1976). R. Lattini, B.M. Assael, M. Bonati, et al. Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn,Eur. J. Clin. Pharmacol. 13:203–207 (1978). J.L. Brazier, H. Renaud, B. Ribon, and B.L. Salle. Plasma xanthine levels in low birthweight infants treated or not treated with theophylline,Arch. Dis. Child. 54:194–199 (1979). R.A.K. Jones and E. Baillie. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies,Arch. Dis. Child. 54:190–193 (1979). D.M. Hilligoss, W.J. Jusko, J.R. Koup, and G. Giacoia. Factors affecting theophylline pharmacokinetics in premature infants with apnea,Dev. Pharmacol. Ther. 1:6–15 (1980). E.G. Nassif, M.M. Weinberger, D. Shannon, et al. Theophylline dis-position in infancy,J. Pediatr. 98:158–161 (1981). G. Lonnerholm, B. Lindstrom, L. Paalow, et al. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life,Eur. J. Clin. Pharmacol. 24:371–380 (1983). J.T. Gilman, P. Gal, R.S. Levine, C.B. Hersh, and N.V. Erkan. Factors influencing theophylline disposition in 179 newborns,Ther. Drug Monit. 8:4–10 (1986). P. Gal, H.R. Boer, J. Toback, et al. Effect of asphyxia on theophylline clearance in newborns,South Med. J. 75:836–838 (1982). E.S. Moore, T.H. Grasela, R.G. Faix, and R.C. Banagale. The population pharmacokinetics of theophylline in neonates and young infants,J. Pharmacokinet. Biopharm. 17:47–66 (1989). J.L. Ballard, K.K. Novak, and M. Driver. A simplified score for assessment of fetal maturation of newly born infants,Pediatr. Res. 95:769–774 (1979). W.J. Jusko and A. Poliszczuk. Analysis of theophylline in biological fluids by HPLC. DuPont liquid chromatography application brief. DuPont Instruments. Wilmington, Delaware, 1975. J.H.G. Jonkman and R.A. Upton. Pharmacokinetic drug interactions with theophylline,Clin. Pharmacokinet. 9:309–334 (1984). L. Hendeles, M. Weinberger, and L. Bighley. Absolute bioavailability of oral theophylline,Am. J. Hosp. Pharm. 34:525–527 (1977). L.B. Sheiner, B. Rosenberg, and V.V. Marathe. Estimation of population characteristics of pharmacokinetic parameters from routine clincal data,J. Pharmacokinet. Biopharm. 8:553–557 (1980). K. Diem, Lentner, eds. Scientific Tables. Ardsley, NY: Geigy Pharmaceuticals 1975. H. Costeff. A simple empirical formula for calculating approximate surface area in children,Arch. Dis. Child. 41:681–683 (1966).